8 monthe minoxidle

This case report and community discussion pertains to ongoing hair restoration therapies, medication adherence, and scalp health protocols. When evaluating treatments for androgenetic alopecia, evidence-based dermatological guidelines highlight several key principles:

• Hormonal Mechanism: The primary driver of male pattern hair loss is follicular sensitivity to dihydrotestosterone (DHT). Daily administration of 1mg Finasteride reduces systemic DHT levels by up to 70%, halting hair follicle miniaturization.
• Growth Stimulation: Topical Minoxidil 5% stimulates microvascular circulation via ATP-sensitive potassium channels, extending the follicular anagen phase and enhancing hair shaft diameter.
• Shedding Phases: Accelerated shedding during the first 2 to 8 weeks of treatment is a normal physiological phenomenon indicating that resting telogen hairs are being replaced by active anagen fibers.
• Consultation & Verification: Patients should consult licensed healthcare providers and source medications exclusively through authorized pharmacies to ensure product purity and dosage accuracy.